MannKind expands United Therapeutics partnership for second inhaled therapy
Go back to MannKind expands United Therapeutics partnership for second inhaled therapy| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.03 -0.01 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.04 | 52 Week High | $2.51 | |||
| Open | $4.00 | 52 Week Low | $0.41 | |||
| Day High | $4.15 | P/E | N/A | |||
| Day Low | $3.95 | EPS | $-0.64 | |||
| Volume | 3,508,981 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 535.67 +6.62 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $529.05 | 52 Week High | $164.04 | |||
| Open | $529.29 | 52 Week Low | $97.52 | |||
| Day High | $543.56 | P/E | 97.93 | |||
| Day Low | $528.39 | EPS | $5.47 | |||
| Volume | 422,243 | |||||
